Now showing items 1-1 of 1

    • Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? 

      McBride, KA; Ballinger, ML; Schlub, TE; Young, M-A; Tattersall, MHN; Kirk, J; Eeles, R; Killick, E; Walker, LG; Shanley, S; Thomas, DM; Mitchell, G (2017-07)
      Germline TP53 mutation carriers are at high risk of developing a range of cancers. Effective cancer risk management is an important issue for these individuals. We assessed the psychosocial impact in TP53 mutation carriers ...